TCR-like CAR-T Cell Therapy(Zhongda Hospital Southeast University)

N/A

Report date: 2024/07/03 21:31:43

Base Information

Drug NameTCR-like CAR-T Cell Therapy(Zhongda Hospital Southeast University)

Drug Alias NameTCR-like CAR-T CellTCR-like CAR-T

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionT lymphocyte replacementsMesothelin modulators

TargetsMesothelin

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaPhase 2 Clinical

Originator CompaniesZhongda Hospital Southeast University

China Registration ClassN/A

Develop Information

Active CompaniesZhongda Hospital Affiliated To Southeast University

Inactive CompaniesN/A

Active IndicationsOvarian Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A